‘Keytruda’ administration test method accepted as new medical technology
A diagnostic check method which is used to decide administration of ‘Keytruda(pembrolizumab),’ an immunotherapy which attracted interests over the health insurance benefit, will be accepted as a new medical technology.
On the 6th, the Ministry of Health and Welfare(MOHW) gave an administrative n...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
